cycloaddit
nsubstitut
c
diethoxyphosphoryl
nitron
nallyl
function
substitut
benzoyl
benzyl
group
proceed
moder
good
diastereoselect
de
synthes
isoxazolidin
phosphon
assess
antivir
activ
broad
rang
dna
rna
virus
compound
exhibit
highest
activ
toward
tk
tk
vzv
strain
mean
ec
valu
rang
mm
ec
isoxazolidin
rang
mm
vzv
tk
strain
mm
vzv
tk
e
strain
isoxazolidin
phosphon
benzyl
substitu
skeleton
isoxazolidin
ring
display
anticytomegaloviru
potenc
time
show
signific
cytostat
activ
human
embryon
lung
fibroblast
use
carri
antivir
assay
well
cell
line
ie
cem
hela
herpesvirus
widespread
among
human
may
caus
mani
diseas
primari
infect
usual
follow
lifelong
latenc
viru
reactiv
usual
occur
immunosuppress
host
infect
varicellazost
viru
vzv
result
varicella
chickenpox
usual
take
mild
cours
children
may
sever
adult
later
establish
latenc
neural
tissu
viru
reactiv
caus
herp
zoster
shingl
often
accompani
neuralg
pain
lead
postherpet
neuralgia
phn
well
complic
loss
vision
zoster
ophthalmicu
case
immunocompet
patient
infect
herpesvirus
requir
antivir
therapi
howev
reactiv
viru
signific
concern
immunocompromis
individu
eg
recipi
solidorgan
hematopoiet
stem
cell
transplant
patient
aggress
chemotherapi
individu
acquir
immunodefici
syndrom
aid
circumst
effici
antivir
drug
crucial
import
effect
treatment
herpesvirida
speci
includ
herp
simplex
viru
hsv
vzv
human
cytomegaloviru
hcmv
avail
hamper
emerg
drug
resist
signific
drug
toxic
antiherpesviru
agent
ganciclovir
foscavir
cidofovir
four
compound
current
licens
treatment
vzv
infect
name
acyclovir
valaciclovir
famciclovir
brivudin
regrett
aid
patient
often
respond
well
acyclovir
therapi
antivir
drug
due
emerg
thymidin
kinasedefici
thymidin
kinasealt
mutat
vzv
therefor
extens
search
new
antivzv
agent
superior
efficaci
compar
current
approv
drug
high
import
numer
structur
diversifi
compound
alreadi
synthes
test
new
potenti
antivzv
agent
includ
bicycl
nucleosid
analogu
nonnucleosid
dna
polymeras
inhibitor
n
amethylbenzyl
narylthiourea
analogu
fig
hand
antivir
activ
sever
fig
discov
recent
year
deriv
report
poss
activ
cell
inhibit
recombin
rt
vitro
potent
inhibitor
rsvinduc
cytopath
effect
ec
mm
sever
analogu
name
prove
activ
toward
respiratori
syncyti
viru
rsv
recent
moieti
success
incorpor
nucleobas
mimet
analogu
nucleotid
compound
show
moder
activ
herp
simplex
virus
ec
mm
well
felin
herp
viru
ec
mm
dihydroxyl
deriv
prove
even
potent
ec
mm
toward
felin
herp
viru
respect
enantiom
inact
sever
function
studi
alloster
inhibitor
polymeras
compound
exhibit
highest
affin
enzym
basi
observ
one
may
conclud
antivir
activ
substitut
aryl
benzyl
benzoyl
group
benefici
recent
success
accomplish
synthes
homonucleosid
analogu
prove
inact
broad
spectrum
dna
rna
virus
appear
slightli
cytostat
toward
sever
cancer
cell
line
howev
later
addit
screen
inhibit
vzv
hcmv
replic
two
compound
b
nbenzoyluracil
r
benzoyl
r
methyl
show
notic
activ
toward
vzv
tabl
base
discoveri
design
new
seri
analogu
scheme
instal
skeleton
either
substitut
benzoyl
group
compound
substitut
benzyl
residu
compound
previous
report
n
allyln
obtain
three
step
overal
yield
start
employ
bisn
n
benzoyl
benzoyl
chlorid
follow
select
n
debenzoyl
subsequ
allyl
howev
procedur
appear
tediou
n
debenzyl
step
least
effect
reason
anoth
strategi
synthes
n
design
reli
nallyl
commerci
avail
isato
anhydrid
follow
subsequ
condens
compound
urea
conclud
n
benzoyl
result
select
benzoyl
chlorid
scheme
moreov
circumst
compound
could
obtain
one
step
benzyl
scheme
cycloaddit
nitron
r
r
bn
respect
n
allyln
carri
c
toluen
tolueneethanol
mixtur
solvent
afford
mixtur
diastereoisomer
isoxazolidin
scheme
tabl
transisom
predomin
cistran
ratio
diastereoisomer
product
determin
basi
p
nmr
spectral
data
reaction
proceed
moder
diastereoselect
de
good
excel
overal
yield
isol
pure
isom
success
accomplish
chromatograph
major
isom
also
minor
isom
elimin
rigid
within
substitut
moieti
benzoyl
substitu
replac
function
benzyl
residu
cycloaddit
nitron
r
r
bn
respect
n
allyln
carri
condit
alreadi
describ
compound
diastereoisomer
cycloadduct
scheme
tabl
form
good
excel
overal
yield
moder
diastereoselect
de
slightli
higher
reaction
nitron
r
bn
chromatograph
isol
pure
isom
achiev
pure
isom
conjug
respect
mixtur
cistran
isom
screen
inhibitor
wide
varieti
dna
rna
virus
use
follow
cellbas
assay
mycophenol
acid
hippeastrum
hybrid
agglutinin
hha
urtica
dioica
agglutinin
uda
use
refer
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
viru
plaqu
format
vzv
reduc
virusinduc
cytopathogen
virus
sever
synthes
inhibit
replic
tk
tk
vzv
strain
tabl
mixtur
mixtur
emerg
activ
deriv
ec
respect
mm
mm
vzv
tk
strain
mm
mm
vzv
tk
strain
two
less
activ
tk
viru
prove
activ
tk
e
strain
compar
refer
drug
acyclovir
data
clearli
indic
novel
deriv
requir
activ
viral
tk
although
significantli
alter
morpholog
cell
antivir
assay
show
consider
cytostat
activ
rang
antivir
activ
compound
mixtur
mixtur
inhibit
vzv
tk
tk
e
virus
ec
rang
mm
compound
mixtur
also
prove
activ
vzv
tk
strain
ec
mm
vzv
tk
strain
ec
mm
slightli
exceed
potenc
vzv
tk
strain
refer
drug
acyclovir
brivudin
ec
mm
respect
howev
major
studi
compound
exhibit
signific
cytotox
mixtur
reduc
cell
growth
cc
concentr
low
mm
almost
two
order
magnitud
lower
acyclovir
cc
mm
among
investig
compound
cisand
found
inact
toward
human
cytomegaloviru
hcmv
strain
hand
isoxazolidin
phosphon
benzyl
substitu
skeleton
isoxazolidin
ring
cisand
show
weak
antivir
activ
ec
rang
mm
tabl
structureact
relationship
observ
reveal
lack
signific
differ
activ
ci
vs
tran
isoxazolidin
higher
potenc
isoxazolidin
carri
nbenzyl
substitu
comparison
nmethyl
counterpart
especi
well
pronounc
n
activ
compound
introduct
fluorin
atom
benzen
ring
either
benzyl
benzoyl
residu
improv
efficaci
substitut
benzoyl
benzyl
moieti
found
effect
vzv
carri
substitut
benzyl
compon
prove
activ
toward
hmcv
synthes
isoxazolidin
phosphon
also
subject
antivir
screen
virus
compound
appear
slightli
activ
herpesvirus
human
coronaviru
tabl
cytostat
inhibitori
concentr
ic
caus
decreas
cell
prolifer
determin
murin
leukemia
human
lymphocyt
cem
human
cervix
carcinoma
hela
immort
human
dermal
microvacsular
endotheli
cell
tabl
among
test
compound
benzyl
substitu
quinazolinon
core
benzyl
group
isoxazolidin
unit
show
signific
cytostat
activ
toward
test
cell
line
cem
cell
line
deriv
activ
refer
drug
notic
replac
benzyl
compon
within
isoxazolidin
moieti
methyl
group
vs
respect
result
decreas
potenc
roughli
order
magnitud
sever
seri
yl
phosphon
yl
phosphon
modifi
moieti
obtain
cycloaddit
nsubstitut
cdiethoxyphosphoryl
nitron
respect
n
allyl
substitut
benzoyl
compound
benzyl
group
compound
synthes
isoxazolidin
phosphon
evalu
varieti
dna
rna
virus
sever
deriv
appear
activ
varicellazost
viru
human
cytomegaloviru
among
test
compound
ec
mm
ec
mm
show
highest
activ
toward
tk
vzv
strain
potenc
deriv
fold
lower
acyclovir
use
refer
drug
hand
compound
mixtur
mixtur
exhibit
potenc
tk
vzv
strain
also
toward
tk
vzv
strain
antitk
vzv
activ
significantli
higher
refer
drug
acyclovir
brivudin
ec
mm
respect
isoxazolidin
phosphon
benzyl
substitu
skeleton
isoxazolidin
ring
cisand
show
activ
toward
human
cytomegaloviru
ec
rang
mm
tabl
cycloaddit
nitron
n
allyln
yield
pure
isom
b
yield
pure
mixtur
cisand
transisom
endow
antivzv
antihcmv
activ
alter
morpholog
cell
use
antivir
assay
concentr
mm
howev
deriv
show
consider
cytostat
activ
cytostat
activ
obtain
compound
also
evalu
cem
hela
cell
among
test
compound
bear
benzyl
substitu
quinazolinon
core
benzyl
group
isoxazolidin
unit
show
signific
ic
mm
activ
toward
test
cell
line
h
c
p
nmr
spectra
taken
cdcl
bruker
avanc
iii
spectromet
mhz
tm
intern
standard
mhz
respect
ir
spectra
measur
infin
ftir
spectromet
melt
point
determin
boetiu
apparatu
uncorrect
element
analys
perform
microanalyt
laboratori
faculti
perkinelm
pe
chn
analyz
follow
adsorb
use
column
chromatographi
merck
silica
gel
mesh
analyt
tlc
merck
tlc
plastic
sheet
silica
gel
f
nmethyland
nbenzylc
diethoxyphosphoryl
nitron
obtain
accord
literatur
procedur
solut
g
mmol
dmf
ml
urea
g
mmol
ad
reaction
mixtur
stir
h
solvent
remov
vacuo
residu
crystal
ethanol
give
pure
yellowish
amorph
solid
mp
c
solut
mmol
acetonitril
ml
triethylamin
ad
mmol
follow
respect
benzoyl
chlorid
mmol
mixtur
stir
room
temperatur
h
solvent
remov
vacuo
residu
dissolv
methylen
chlorid
ml
wash
water
ml
organ
layer
dri
mgso
concentr
purifi
column
chromatographi
tabl
inhibitori
effect
test
compound
prolifer
murin
leukemia
human
tlymphocyt
cem
human
cervix
carcinoma
hela
immort
human
dermal
microvascular
endotheli
cell
solut
mmol
acetonitril
ml
potassium
hydroxid
mmol
ad
follow
respect
benzyl
chlorid
mmol
reaction
mixtur
stir
c
h
solvent
remov
vacuo
residu
dissolv
methylen
chlorid
ml
wash
water
ml
organ
layer
dri
mgso
concentr
crude
product
purifi
column
chromatographi
methylen
chloridehexan
mixtur
vv
crystal
chloroformpetroleum
ether
mixtur
amorph
solid
compound
evalu
differ
herpesvirus
includ
herp
simplex
viru
type
strain
ko
thymidin
kinasedefici
tk
e
ko
strain
resist
acv
acv
r
herp
simplex
viru
type
strain
g
varicellazost
viru
vzv
strain
oka
tk
e
vzv
strain
human
cytomegaloviru
hcmv
strain
davi
well
felin
herp
viru
fhv
poxviru
vaccinia
viru
lederl
strain
viru
sindbi
viru
coxsacki
viru
punta
toro
viru
respiratori
syncyti
viru
rsv
felin
coronoviru
fipv
influenza
viru
subtyp
influenza
b
viru
human
immun
defici
viru
antivir
assay
hiv
base
inhibit
virusinduc
cytopath
plaqu
format
human
embryon
lung
hel
fibroblast
african
green
monkey
kidney
cell
vero
human
epitheli
cervix
carcinoma
cell
hela
crandellre
felin
kidney
cell
crfk
madin
darbi
canin
kidney
cell
mdck
confluent
cell
cultur
microtit
plate
inocul
viru
viru
dose
infect
cell
cultur
plaqu
form
unit
pfu
cell
cultur
incub
presenc
vari
concentr
test
compound
viral
cytopath
plaqu
format
vzv
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
virusinduc
cytopath
viral
plaqu
format
cytotox
test
compound
express
minimum
cytotox
concentr
mcc
compound
concentr
caus
microscop
detect
alter
cell
morpholog
murin
leukemia
human
tlymphocyt
cem
human
cervix
carcinoma
hela
immort
human
dermal
microvascular
endotheli
cell
suspend
cellsml
cultur
medium
ml
cell
suspens
ad
ml
appropri
dilut
test
compound
mlwell
microtit
plate
incub
c
two
three
cem
four
hela
day
cell
number
determin
use
coulter
counter
defin
compound
concentr
requir
inhibit
cell
prolifer
